Related Experiment Video
Updated: May 9, 2025

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
Published on: November 1, 2015
Exploring the Causal Link Between Systemic Lupus Erythematosus and Stroke Risk Through Mendelian Randomization Study
Lingwen Zhang1, Yaxin Li2, Wenhui Fan2
1Department of Neurology, The Sixth People's Hospital of Chengdu, Chengdu, Sichuan, China.
This study used Mendelian randomization to investigate the genetic link between systemic lupus erythematosus (SLE) and stroke risk. Findings suggest SLE causally increases the risk of ischemic stroke, highlighting the need for proactive stroke prevention in SLE patients.
Area of Science:
- Genetics
- Epidemiology
- Rheumatology
Background:
- Observational studies suggest a link between systemic lupus erythematosus (SLE) and stroke.
- The genetic basis for this association requires further investigation.
- Mendelian randomization (MR) is employed to explore causal relationships.
Purpose of the Study:
- To investigate the potential causal relationship between SLE and stroke risk using genetic data.
- To differentiate the impact of SLE on various stroke subtypes.
Main Methods:
- Utilized summary-level statistics from large genome-wide association studies (GWASs) for SLE and stroke.
- Primary analysis employed the inverse variance weighted (IVW) method.
- Sensitivity and heterogeneity analyses were conducted to ensure result robustness.
Main Results:
- A causal association was found between SLE and an increased risk of ischemic stroke (OR = 1.039, p = 0.002).
- No significant genetic association was observed between SLE and large artery stroke, cardioembolic stroke, small vessel stroke, or intracerebral hemorrhage.
Conclusions:
- This MR study provides genetic evidence for a causal link between SLE and increased ischemic stroke risk.
- Emphasizes the importance of monitoring and preventing ischemic stroke in SLE patients.
- Acknowledges potential ethnic-specific genomic heterogeneity affecting results.
More Related Videos
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024